Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab plus platinum-doublet chemotherapy vs placebo plus platinum-doublet chemotherapy in cancer (Japan, jRCT2080225131)
jRCT2080225131Phase 3Completed
- Start
- Mar 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 3, randomised, double-blind trial in cancer comparing Nivolumab plus platinum-based chemotherapy with Placebo plus platinum-based chemotherapy (2 arms). Started Mar 2020; status: completed.
02
Drugs
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080225131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225131.